Cardiovascular Disease Risk
Showing 9951 - 9975 of >10,000
COVID-19 Trial in Chicago (Tocilizumab)
Completed
- COVID-19
-
Chicago, IllinoisUniversity of Chicago Medicine
May 13, 2022
Metastatic NSCLC Trial in Worldwide (Pembrolizumab, Lenvatinib, Docetaxel)
Active, not recruiting
- Metastatic Non-Small Cell Lung Cancer
- Pembrolizumab
- +2 more
-
Bakersfield, California
- +142 more
Sep 1, 2022
Blood Brain Barrier Defect, Sleep Deprivation, Sleep Apnea Trial in Berlin (Diagnostic Test)
Withdrawn
- Blood Brain Barrier Defect
- +3 more
- Diagnostic Test
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Jul 25, 2022
Wheatgrass and Tulsi Formulation or Individuals Taken With Other
Not yet recruiting
- Blood Pressure, High
- +3 more
- Observation study
-
Pune, Maharashtra, IndiaSinhgad college of Pharmacy
May 5, 2023
Angiotensin Converting Enzyme rs Gene Polymorphism and
Recruiting
- Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases
- DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD
-
Sohag, EgyptSohag university Hospital
Sep 20, 2023
MINOCA Trial in Bergen (CT coronary angiography and [12N] NH3 PET-MR)
Recruiting
- MINOCA
- CT coronary angiography and [12N] NH3 PET-MR
-
Bergen, NorwayDepartment of Clinical Science, University of Bergen
Jan 3, 2023
Describe to Better Understand, Mealtime of People With
Not yet recruiting
- Parkinson Disease
- Deglutition Disorders
-
Toulouse, Haute-Garonne, FranceCentre Expert Parkinson
May 31, 2023
Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland
Not yet recruiting
- Allogeneic Stem Cell Transplant Candidate
- +4 more
- Cellular therapy product
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 1, 2022
Obesity Trial in Atlanta (PATH Intervention, Control Group, Physical activity tracker)
Not yet recruiting
- Obesity
- PATH Intervention
- +3 more
-
Atlanta, GeorgiaEmory University
Nov 7, 2023
Parkinson Disease Trial in Ghent (Baseline assessment of demographic, anthropometric and clinical characteristics, Locomotor
Active, not recruiting
- Parkinson Disease
- Baseline assessment of demographic, anthropometric and clinical characteristics
- +3 more
-
Ghent, Belgium
- +1 more
Oct 20, 2021
Emergencies Trial in Hangzhou (Aortic balloon assisted resuscitation, Traditional cardiopulmonary resuscitation, Esophageal
Recruiting
- Emergencies
- Aortic balloon assisted resuscitation
- +3 more
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, Zhejiang University School of Medici
Jun 28, 2021
COVID-19 Trial in France (Diagnostic test Covid-19)
Completed
- COVID-19
- Diagnostic test Covid-19
-
Roubaix, France
- +3 more
May 9, 2022
Endocarditis, Bacterial, Aneurysm, Intracranial Mycotic Trial (Brain MRI, digital subtraction angiography (DSA))
Not yet recruiting
- Endocarditis, Bacterial
- Aneurysm, Intracranial Mycotic
- Brain MRI
- digital subtraction angiography (DSA)
- (no location specified)
Dec 7, 2021
Patients With Chronic Obstructive Pulmonary Disease
Recruiting
- COPD
- +2 more
- Assessments of the sympathetic nerve activity axis
- +4 more
-
Aachen, GermanyRWTH Aachen University
Oct 9, 2022
Cardiovascular Diseases Trial in Belém (Physical exercise, monitoring)
Completed
- Cardiovascular Diseases
- Physical exercise
- monitoring
-
Belém, Pará, BrazilUniversidade da Amazônia
Aug 11, 2020
Quantifying Body Composition and Liver Disease in Children Using
Recruiting
- NAFLD
- NASH - Nonalcoholic Steatohepatitis
- Magnetic resonance imaging (MRI)
- +2 more
-
Los Angeles, CaliforniaUCLA Medical Center
Jan 5, 2022
Healthy Aging Trial in Neuchâtel (Arm-in-arm gait training, Normal gait training)
Recruiting
- Healthy Aging
- Arm-in-arm gait training
- Normal gait training
-
Neuchâtel, SwitzerlandHaute-Ecole Arc Santé
Jan 27, 2023
Calciphylaxis : Population, Risk Factors, Diagnostic Practice,
Completed
- Calciphylaxis
- Calcific Uremic Arteriolopathy
- (no location specified)
Sep 20, 2021
Chronic Lymphocytic Leukemia (CLL) Trial
Completed
- Chronic Lymphocytic Leukemia (CLL)
- (no location specified)
Apr 5, 2022
Healthy Trial in Busan (EB-203, Placebo)
Recruiting
- Healthy
- EB-203
- Placebo
-
Busan, Korea, Republic ofBusan Paik Hospital, Inje University
Sep 11, 2022
Called FLAMINgO to Learn More About Treatment Combination of
Active, not recruiting
- Chronic Kidney Disease
- Type 2 Diabetes
- Finerenone (Kerendia, BAY94-8862)
- Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
-
Whippany, New JerseyBayer
Jan 19, 2023
Early Referral to Radiofrequency Ablation in Symptomatic Atrial
Not yet recruiting
- Atrial Fibrillation
- Radiofrequency Ablation
- Radiofrequency ablation
- (no location specified)
Sep 24, 2022